Liangpunsakul Lab

The Liangpunsakul Lab, led by Suthat Liangpunsakul, MD, focuses on the identification of non-invasive biomarkers to screen for excessive alcohol use and the molecular mechanism, risk factors, and treatment for alcohol-associated liver disease (ALD). This research spans from basic molecular mechanism in mouse models, translational research studies using human biosamples to explore the role of immune cells in the pathogenesis of ALD. The lab is also conducting a clinical trial to determine the novel treatment for patients with alcoholic cirrhosis. This research supported by the US Department of Veterans Affairs (Merit Review) as well as the National Institute of Health (NIAAA and NIDDK).